Bedside SpO2 Patient Monitoring System - India CDSCO Medical Device Registration

Bedside SpO2 Patient Monitoring System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/001299_37f864b70f1c23826abda24a1f67e211_ec63f8ec8a4ee14ba3cd6269402b38f7. This device is marketed under the brand name Nellcor. The license holder is India Medtronic Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

Bedside SpO2 Patient Monitoring System

UID: IMP/MD/2023/001299_37f864b70f1c23826abda24a1f67e211_ec63f8ec8a4ee14ba3cd6269402b38f7

Brand Name

Nellcor

License Holder

India Medtronic Private Limited

Device Class

Class C

Approving Authority

CDSCO

Product Information

The Nellcor™ Bedside SpO2 Patient Monitoring System is indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (Nellcor) and pulse rate. The Nellcor™ Bedside SpO2 Patient Monitoring System is intended for prescription use only with neonatal, pediatric, and adult patients, and for patients who are well or poorly perfused, in hospitals, hospital-type facilities, and intra-hospital transport.